Back to top
more

uniQure (QURE)

(Delayed Data from NSDQ)

$4.53 USD

4.53
354,544

-0.01 (-0.22%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $4.53 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth C Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for QURE

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for uniQure NV falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 618 353 556 245 378
Receivables 4 102 59 7 1
Notes Receivable 0 0 0 0 0
Inventories 12 7 0 0 0
Other Current Assets 18 15 13 7 5
Total Current Assets 652 477 628 259 384
Net Property & Equipment 47 51 44 32 29
Investments & Advances 0 40 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 12 15 16 16 0
Intangibles 87 84 90 4 6
Deposits & Other Assets 5 6 6 3 3
Total Assets 832 705 809 340 449
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 7 11 3 4 6
Current Portion Long-Term Debt 0 0 0 0 12
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 31 31 28 18 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 28 26 0 0 8
Total Current Liabilities 74 76 37 27 32
Mortgages 0 0 0 0 0
Deferred Taxes/Income 8 8 13 0 23
Convertible Debt 0 0 0 0 0
Long-Term Debt 102 103 101 36 36
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 413 10 34 3 4
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 624 229 213 96 126
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 3 3 3 3 3
Capital Surplus 1,149 1,113 1,077 1,016 987
Retained Earnings -890 -582 -455 -785 -660
Other Equity -54 -58 -29 10 -7
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 208 476 596 244 323
Total Liabilities & Shareholder's Equity 832 705 809 340 449
Total Common Equity 208 476 596 244 323
Shares Outstanding 47.80 46.80 46.20 44.50 43.60
Book Value Per Share 4.34 10.17 12.90 5.48 7.41

Fiscal Year End for uniQure NV falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 618 659 629 315
Receivables NA 4 2 103 105
Notes Receivable NA 0 0 0 0
Inventories NA 12 16 10 7
Other Current Assets NA 18 17 16 15
Total Current Assets NA 652 694 757 443
Net Property & Equipment NA 47 46 49 50
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 12 12 14 14
Intangibles NA 87 83 86 86
Deposits & Other Assets NA 5 6 6 6
Total Assets NA 832 872 943 631
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 7 6 9 9
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 31 28 24 23
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 28 27 28 27
Total Current Liabilities NA 74 69 68 66
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 8 5 7 7
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 102 101 101 103
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 399 383 11
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 624 603 589 218
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 3 3 3 3
Capital Surplus NA 1,149 1,142 1,131 1,122
Retained Earnings NA -890 -817 -728 -659
Other Equity NA -54 -59 -52 -52
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 208 269 353 413
Total Liabilities & Shareholder's Equity NA 832 872 943 631
Total Common Equity 0 208 269 353 413
Shares Outstanding 47.80 47.80 47.80 47.70 46.90
Book Value Per Share 0.00 4.34 5.62 7.41 8.80